Mario Raviglione
Direktor/Vorstandsmitglied bei Global Alliance for TB Drug Development
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Melvin Spigelman | M | 75 |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 21 Jahre |
| David Norton | M | 72 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 11 Jahre |
| Shalini Sharp | F | 49 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 9 Jahre |
| Paul Sekhri | M | 66 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | - |
| Sangita Reddy | M | 61 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 3 Jahre |
| Sundar Kodiyalam | M | 62 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 3 Jahre |
| Kim Schwartz | F | - |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 2 Jahre |
| Jane Griffiths | M | 69 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 4 Jahre |
| Willo Brock | M | - |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 10 Jahre |
| Nancy Miller-Rich | F | 65 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 6 Jahre |
| Ambassador Eric Goosby | M | - |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 3 Jahre |
| Ariel Pablos-Méndez | M | - |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | - |
| Mitchell Warren | M | - |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | - |
| Rasha Hibri | F | - |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Caterina Bima | F | 64 |
University of Turin
| 7 Jahre |
| Bruce Carter | M | 80 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | - |
| Riccardo Montanaro | M | 66 |
University of Turin
| 3 Jahre |
| Paolo Gibello Ribatto | M | - |
University of Turin
| 4 Jahre |
| Paola Marini | M | 66 |
University of Turin
| 4 Jahre |
| Andrea Maggia | M | - |
University of Turin
| 6 Jahre |
| Lucia Morselli | M | 67 |
University of Turin
| 2 Jahre |
| Maria Grazia Roncarolo | M | 69 |
University of Turin
| 3 Jahre |
| Claudio Serracane | M | 67 |
University of Turin
| 4 Jahre |
| Andrea Beltratti | M | 65 |
University of Turin
| 4 Jahre |
| Fabio Pasquini | M | 70 |
University of Turin
| 4 Jahre |
| Riccardo Ranalli | M | 68 |
University of Turin
| 4 Jahre |
| Georgios Vlamakis | M | 75 |
University of Turin
| 4 Jahre |
| Gianpiero Giacardi | M | 66 |
University of Turin
| 3 Jahre |
| Paolo Cafasso | M | 67 |
University of Turin
| 4 Jahre |
| Roberto Orecchia | M | 71 |
University of Turin
| 4 Jahre |
| G. Botta | M | 70 |
University of Turin
| 4 Jahre |
| Claudio Recchi | M | 69 |
University of Turin
| 4 Jahre |
| Daniela Ovazza | F | 67 |
University of Turin
| 4 Jahre |
| Enrico Mario Amo | M | 67 |
University of Turin
| 4 Jahre |
| Alessandra Trombetta | F | 65 |
University of Turin
| 4 Jahre |
| Galeazzo Scarampi del Cairo | M | 68 |
University of Turin
| 3 Jahre |
| Ezio Giovanni Basso | M | 69 |
University of Turin
| 4 Jahre |
| Vittorio Rabajoli | M | - |
University of Turin
| 4 Jahre |
| Camillo Venesio | M | 70 |
University of Turin
| 4 Jahre |
| Oscar Pepino | M | 71 |
University of Turin
| 4 Jahre |
| Stefano Marsaglia | M | 69 |
University of Turin
| 4 Jahre |
| Carlo Pavesio | M | 68 |
University of Turin
| 3 Jahre |
| Andrea Dogliotti | M | 74 |
University of Turin
| 4 Jahre |
| Umberto Bocchino | M | 64 |
University of Turin
| 4 Jahre |
| Riccardo Lodigiani | M | 66 |
University of Turin
| 4 Jahre |
| Gilbert Marks | M | 66 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 12 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Italien | 30 | 65,22% |
| Vereinigte Staaten | 16 | 34,78% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Mario Raviglione
- Persönliches Netzwerk
